Tethis takes control of See.d platform in MACS transfer, partners with Everex

Verifying
  • Tethis completed MACS's transfer of the See.d software and engineering business unit.
  • Everex will support See.d production and future scale-up under a long-term agreement.
  • See.d instruments support research programs at Sheba Medical Center, Weill Cornell Medicine and ETH Zurich.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.